Folate-Functionalized PAMAM–Nanodiamond Conjugates for Sustained pH-Dependent Cabazitaxel Release and Enhanced Cytotoxicity in Prostate Cancer Cells

Abstract Cabazitaxel (CTX) is an effective chemotherapeutic agent for advanced prostate cancer, but limited aqueous solubility and systemic toxicity motivate alternative delivery strategies. Herein, we developed a folate receptor-targeted nanodiamond-based nanoconjugate (ND-PAMAM-FA-CTX) for selective and controlled drug delivery. Cabazitaxel was first converted to CTX-hemisuccinate and subsequently conjugated to a fourth-generation polyamidoamine (PAMAM) dendrimer along with folic acid (FA), followed by covalent attachment to nanodiamonds (NDs). Comprehensive physicochemical characterization confirmed the successful construction of the nanoconjugate while preserving the structural integrity of the nanodiamond core. The resulting platform exhibited high CTX-loading capacity and a sustained, pH-responsive drug-release profile, with enhanced release under acidic conditions relevant to the tumor microenvironment. The drug-free carrier showed excellent biocompatibility, whereas ND-PAMAM-FA-CTX demonstrated superior anticancer activity against folate receptor (FAR)-overexpressing PC3 prostate cancer cells compared with free CTX and nontargeted controls. Flow cytometry and confocal microscopy revealed significantly enhanced cellular uptake mediated by folate receptor-dependent endocytosis, which was further confirmed through competitive inhibition studies using free folic acid. Moreover, ND-PAMAM-FA-CTX exhibited a low nanomolar IC50 value (∼5 nM) and markedly suppressed PC3 cell migration. Overall, these findings demonstrate that ND-PAMAM-FA-CTX is a promising targeted nanotherapeutic platform that combines selective cellular delivery and controlled drug release with enhanced efficacy, offering potential for future targeted chemotherapy applications.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-11-16
DOI
https://doi.org/10.1021/acsomega.6c10278
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Folate-Functionalized PAMAM–Nanodiamond Conjugates for Sustained pH-Dependent Cabazitaxel Release and Enhanced Cytotoxicity in Prostate Cancer Cells

Sachin Patil, Puli Chandramouli Reddy, Bimlesh Lochab, Vishnu S. Mishra et al.
1 links
ACS Omega
Nanoparticle-Based Drug Delivery
article

Folate-Functionalized PAMAM–Nanodiamond Conjugates for Sustained pH-Dependent Cabazitaxel Release and Enhanced Cytotoxicity in Prostate Cancer Cells

Sachin Patil, Puli Chandramouli Reddy, Bimlesh Lochab, Vishnu S. Mishra, Nisha Yadav
article en

Abstract

Abstract Cabazitaxel (CTX) is an effective chemotherapeutic agent for advanced prostate cancer, but limited aqueous solubility and systemic toxicity motivate alternative delivery strategies. Herein, we developed a folate receptor-targeted nanodiamond-based nanoconjugate (ND-PAMAM-FA-CTX) for selective and controlled drug delivery. Cabazitaxel was first converted to CTX-hemisuccinate and subsequently conjugated to a fourth-generation polyamidoamine (PAMAM) dendrimer along with folic acid (FA), followed by covalent attachment to nanodiamonds (NDs). Comprehensive physicochemical characterization confirmed the successful construction of the nanoconjugate while preserving the structural integrity of the nanodiamond core. The resulting platform exhibited high CTX-loading capacity and a sustained, pH-responsive drug-release profile, with enhanced release under acidic conditions relevant to the tumor microenvironment. The drug-free carrier showed excellent biocompatibility, whereas ND-PAMAM-FA-CTX demonstrated superior anticancer activity against folate receptor (FAR)-overexpressing PC3 prostate cancer cells compared with free CTX and nontargeted controls. Flow cytometry and confocal microscopy revealed significantly enhanced cellular uptake mediated by folate receptor-dependent endocytosis, which was further confirmed through competitive inhibition studies using free folic acid. Moreover, ND-PAMAM-FA-CTX exhibited a low nanomolar IC50 value (∼5 nM) and markedly suppressed PC3 cell migration. Overall, these findings demonstrate that ND-PAMAM-FA-CTX is a promising targeted nanotherapeutic platform that combines selective cellular delivery and controlled drug release with enhanced efficacy, offering potential for future targeted chemotherapy applications.

ACS Omega
Shiv Nadar University (IN)
Shiv Nadar University
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon